Financhill
Sell
42

SGML Quote, Financials, Valuation and Earnings

Last price:
$6.65
Seasonality move :
33.08%
Day range:
$6.56 - $7.00
52-week range:
$4.25 - $15.56
Dividend yield:
0%
P/E ratio:
81.98x
P/S ratio:
4.75x
P/B ratio:
6.98x
Volume:
2.8M
Avg. volume:
2.2M
1-year change:
-45%
Market cap:
$740M
Revenue:
$145.4M
EPS (TTM):
-$0.36
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- $136.6M $145.4M
Revenue Growth (YoY) -- -- -- -- 6.47%
 
Cost of Revenues $46.4K $45.5K -- $69.6M $114.6M
Gross Profit -$46.4K -$45.5K -- $67M $30.8M
Gross Profit Margin -- -- -- 49.05% 21.21%
 
R&D Expenses $307.7K $975.7K -- -- --
Selling, General & Admin $904.2K $24M $93.6M $78.5M $28.4M
Other Inc / (Exp) $383.3K -$1.3M $1.5M $6.3M -$32M
Operating Expenses $1.2M $25M $95.3M $85.2M $38.5M
Operating Income -$1.3M -$25M -$95.3M -$18.2M -$7.6M
 
Net Interest Expenses -- -- -- $11.8M $23.4M
EBT. Incl. Unusual Items -$1.2M -$26.7M -$93.7M -$23.8M -$63M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $5.1M -$14.2M
Net Income to Company -$1.2M -$26.7M -$93.7M -$28.8M -$48.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.2M -$26.7M -$93.7M -$28.8M -$48.8M
 
Basic EPS (Cont. Ops) -$0.02 -$0.31 -$0.93 -$0.26 -$0.44
Diluted EPS (Cont. Ops) -$0.02 -$0.31 -$0.93 -$0.26 -$0.44
Weighted Average Basic Share $72.2M $86.6M $101M $108M $110.8M
Weighted Average Diluted Share $72.2M $86.6M $101M $108M $110.8M
 
EBITDA -$845.5K -$26.3M -$93.4M -$4.2M -$28M
EBIT -$891.9K -$26.3M -$93.5M -$9.9M -$41.3M
 
Revenue (Reported) -- -- -- $136.6M $145.4M
Operating Income (Reported) -$1.3M -$25M -$95.3M -$18.2M -$7.6M
Operating Income (Adjusted) -$891.9K -$26.3M -$93.5M -$9.9M -$41.3M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- $37.2M $47.7M
Revenue Growth (YoY) -- -- -- -- 28.15%
 
Cost of Revenues $10.3K $17.6K -- $28.6M $34.2M
Gross Profit -$10.3K -$17.6K -- $8.6M $13.5M
Gross Profit Margin -- -- -- 23.01% 28.22%
 
R&D Expenses $95.9K $326.8K $553K -- --
Selling, General & Admin $4.7M $10.9M $21.6M $7.5M $5.7M
Other Inc / (Exp) -$129.9K $1.5M $2.4M -$3.2M $7.3M
Operating Expenses $4.8M $11.2M $25.2M $8.9M $6.7M
Operating Income -$4.8M -$11.2M -$25.2M -$371K $6.7M
 
Net Interest Expenses -- -- -- $3.9M $4.3M
EBT. Incl. Unusual Items -$5.1M -$9.7M -$22.1M -$7.4M $9.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$471K $5M
Net Income to Company -$5.1M -$9.7M -$22.1M -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$5.1M -$9.7M -$22.1M -$6.9M $4.7M
 
Basic EPS (Cont. Ops) -$0.06 -$0.10 -$0.21 -$0.06 $0.04
Diluted EPS (Cont. Ops) -$0.06 -$0.10 -$0.21 -$0.06 $0.04
Weighted Average Basic Share $82.8M $99.8M $102.3M $110.5M $111.3M
Weighted Average Diluted Share $82.8M $99.8M $102.3M $110.5M $111.3M
 
EBITDA -$5M -$9.7M -$21.7M -$2.5M $14.9M
EBIT -$5M -$9.7M -$21.7M -$2.5M $14.9M
 
Revenue (Reported) -- -- -- $37.2M $47.7M
Operating Income (Reported) -$4.8M -$11.2M -$25.2M -$371K $6.7M
Operating Income (Adjusted) -$5M -$9.7M -$21.7M -$2.5M $14.9M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- -- $155.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $43.6K $53.2K -- -- $119.7M
Gross Profit -$43.6K -$53.2K -$21K $75.6M $35.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $354.8K $1.2M -- -- --
Selling, General & Admin $5.4M $30.2M $105.3M $64.2M $26.1M
Other Inc / (Exp) -$62.6K $335.8K $2.3M $827.2K -$21.6M
Operating Expenses $5.7M $31.5M $110.9M $70.6M $36.1M
Operating Income -$5.8M -$31.5M -$110.9M $5M -$670.6K
 
Net Interest Expenses -- -- -- $12.1M $23.5M
EBT. Incl. Unusual Items -$6.2M -$31.5M -$107.9M -$10M -$45.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $4.6M -$8.7M
Net Income to Company -$6.1M -$31.4M -$106.1M -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$6.2M -$31.5M -$107.9M -$14.6M -$37M
 
Basic EPS (Cont. Ops) -$0.08 -$0.34 -$1.06 -$0.11 -$0.35
Diluted EPS (Cont. Ops) -$0.08 -$0.34 -$1.06 -$0.11 -$0.36
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$5.8M -$31.2M -$107.2M $13.7M -$17.1M
EBIT -$5.8M -$31.2M -$107.3M $8M -$23.9M
 
Revenue (Reported) -- -- -- -- $155.2M
Operating Income (Reported) -$5.8M -$31.5M -$110.9M $5M -$670.6K
Operating Income (Adjusted) -$5.8M -$31.2M -$107.3M $8M -$23.9M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- $37.2M $47.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10.3K $17.6K -- $28.6M $34.2M
Gross Profit -$10.3K -$17.6K -- $8.6M $13.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $95.9K $326.8K $553K -- --
Selling, General & Admin $4.7M $10.9M $21.6M $7.5M $5.7M
Other Inc / (Exp) -$129.9K $1.5M $2.4M -$3.2M $7.3M
Operating Expenses $4.8M $11.2M $25.2M $8.9M $6.7M
Operating Income -$4.8M -$11.2M -$25.2M -$371K $6.7M
 
Net Interest Expenses -- -- -- $3.9M $4.3M
EBT. Incl. Unusual Items -$5.1M -$9.7M -$22.1M -$7.4M $9.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -$471K $5M
Net Income to Company -$5.1M -$9.7M -$22.1M -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$5.1M -$9.7M -$22.1M -$6.9M $4.7M
 
Basic EPS (Cont. Ops) -$0.06 -$0.10 -$0.21 -$0.06 $0.04
Diluted EPS (Cont. Ops) -$0.06 -$0.10 -$0.21 -$0.06 $0.04
Weighted Average Basic Share $82.8M $99.8M $102.3M $110.5M $111.3M
Weighted Average Diluted Share $82.8M $99.8M $102.3M $110.5M $111.3M
 
EBITDA -$5M -$9.7M -$21.7M -$2.5M $14.9M
EBIT -$5M -$9.7M -$21.7M -$2.5M $14.9M
 
Revenue (Reported) -- -- -- $37.2M $47.7M
Operating Income (Reported) -$4.8M -$11.2M -$25.2M -$371K $6.7M
Operating Income (Adjusted) -$5M -$9.7M -$21.7M -$2.5M $14.9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $10.6M $121M $71M $48.5M $46M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $22.4M $11.6M
Inventory -- -- -- $14.7M $16.2M
Prepaid Expenses $147.4K $267.5K $1.2M $5.3M $9.7M
Other Current Assets $1.4K -- $8.2M $3.3M $3M
Total Current Assets $11M $121.7M $84.4M $107.6M $93M
 
Property Plant And Equipment $14.9M $31.7M $143.1M $236.7M $188.6M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $87.1K $72.2K -- -- --
Other Long-Term Assets -- -- $150.3K $11.6M $12.7M
Total Assets $26M $153.5M $227.6M $367.3M $327.9M
 
Accounts Payable $1.5M $2.8M $19.3M $53.6M $32.7M
Accrued Expenses -- $4.7K $301.4K $1.9M $2M
Current Portion Of Long-Term Debt $1.5M -- -- $21.8M $61.7M
Current Portion Of Capital Lease Obligations $7.1K $294.9K $501K $1.6M $1.8M
Other Current Liabilities $56.6K -- $5.2M $1.5M $5.4M
Total Current Liabilities $5.4M $3.6M $27.6M $92.2M $109M
 
Long-Term Debt $3.3M $3.1M $57.1M $107M $112.3M
Capital Leases -- -- -- -- --
Total Liabilities $9M $8.4M $92.7M $205.8M $235.3M
 
Common Stock $42.3M $176.3M $203.9M $291M $302.9M
Other Common Equity Adj -$2.2M -$2.7M -$2.2M $1.5M -$15.7M
Common Equity $17.1M $145M $134.9M $161.5M $92.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $17.1M $145M $134.9M $161.5M $92.6M
 
Total Liabilities and Equity $26M $153.5M $227.6M $367.3M $327.9M
Cash and Short Terms $10.6M $121M $71M $48.5M $46M
Total Debt -- -- -- $128.8M $174M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $37.1M $112.9M $68.6M $108.3M $31.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $507.9K -- -- $29.1M $27M
Inventory -- -- $533.1K $14.4M $21.2M
Prepaid Expenses -- $1.1M $14.2M $6.2M $7.1M
Other Current Assets -- -- -- $2.2M $2.3M
Total Current Assets $37.6M $114.3M $84M $175.2M $97.9M
 
Property Plant And Equipment $16.8M $42.4M $184.7M $230.9M $203.9M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- $82.5K $216.6K -- --
Other Long-Term Assets -- -- -- $11.6M $12.7M
Total Assets $54.5M $156.8M $268.9M $430.2M $348.3M
 
Accounts Payable $546.6K $1.1M $17M $52.5M $38.6M
Accrued Expenses -- -- $2.6M $3.7M $3.5M
Current Portion Of Long-Term Debt $193.4K -- $10.4M $94.1M $55.8M
Current Portion Of Capital Lease Obligations $6.7K $24.8K $1M $1.2M $1.9M
Other Current Liabilities -- $97.7K $3.8M $1.4M $6.9M
Total Current Liabilities $3.1M $1.7M $39.3M $164.4M $114.6M
 
Long-Term Debt $3.2M $3.2M $89.6M $107.7M $112.9M
Capital Leases -- -- -- -- --
Total Liabilities $6.4M $5.2M $137.9M $278.2M $242.2M
 
Common Stock $73.2M $184M $220.2M $303M $327M
Other Common Equity Adj -$3.1M -$1.7M $254.3K -$155.4K -$18.5M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $48.1M $151.6M $131M $151.9M $106.1M
 
Total Liabilities and Equity $54.5M $156.8M $268.9M $430.2M $348.3M
Cash and Short Terms $37.1M $112.9M $68.6M $108.3M $31.1M
Total Debt -- -- -- $201.8M $168.7M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$1.2M -$26.7M -$93.7M -$28.8M -$48.8M
Depreciation & Amoritzation $46.4K $45.5K -- -- --
Stock-Based Compensation $270.5K $20.7M $82.2M $35.4M $7.8M
Change in Accounts Receivable -$108.1K -- -- -$31.5M -$5.6M
Change in Inventories -- -- -- -$14M -$5.9M
Cash From Operations -$1.9M -$3.3M -$4M -$23.2M -$17M
 
Capital Expenditures -- -- -- $34.5M $16.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.1M -$14.4M -$97.6M -$62M -$22.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $57.7M $69.8M $169.1M
Long-Term Debt Repaid -$832.2K -$3.9M -$747.1K -$11.1M -$118.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$165.1K
Cash From Financing $13.8M $129.3M $58.8M $58.7M $50.2M
 
Beginning Cash (CF) $81.3K $10.6M $113.7M $72.6M $44.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $10.9M $111.6M -$42.9M -$26.5M $10.6M
Ending Cash (CF) $10.6M $121M $71M $48.5M $46M
 
Levered Free Cash Flow -$3M -$17.7M -$87.7M -$57.7M -$33M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$5.1M -$9.7M -$22.1M -- --
Depreciation & Amoritzation $10.3K $17.6K $25.1K -- --
Stock-Based Compensation $4.3M $10.1M $14.6M -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$1.7M -$3.5M -$26M -$11.5M -$2.2M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.4M -$8M -$20.6M -$5.8M -$4.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $42.4M -- --
Long-Term Debt Repaid -$1.5M -$261.1K -$140.5K -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $29.7M $1.6M $42.3M $78.6M -$10.8M
 
Beginning Cash (CF) $10.7M $123.6M $71.2M $48.6M $45.9M
Foreign Exchange Rate Adjustment -$179.8K -$853.1K $1.7M -$1.8M $2.9M
Additions / Reductions $26.6M -$9.9M -$4.3M $61.4M -$17.8M
Ending Cash (CF) $37.1M $112.9M $68.6M $108.2M $31.1M
 
Levered Free Cash Flow -$3.1M -$11.5M -$45.4M -$11.5M -$2.2M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$6.1M -$31.4M -$106.1M -- --
Depreciation & Amoritzation $44.6K $52.8K $7.5K -- --
Stock-Based Compensation $4.5M $26.5M $86.7M $20.9M $7.8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$3.3M -$5M -$26.5M -$8.7M -$7.7M
 
Capital Expenditures -- -- -- -$1.4M $16.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2.2M -$21M -$110.2M -$47.1M -$21.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2.3M -$2.7M -$626.5K -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $43M $101.2M $99.5M $95M -$39.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $37.4M $75.1M -$37.3M $39.1M -$68.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$5.5M -$26.1M -$121.6M -$23.8M -$7.7M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$5.1M -$9.7M -$22.1M -- --
Depreciation & Amoritzation $10.3K $17.6K $25.1K -- --
Stock-Based Compensation $4.3M $10.1M $14.6M -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$1.7M -$3.5M -$26M -$11.5M -$2.2M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.4M -$8M -$20.6M -$5.8M -$4.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $42.4M -- --
Long-Term Debt Repaid -$1.5M -$261.1K -$140.5K -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $29.7M $1.6M $42.3M $78.6M -$10.8M
 
Beginning Cash (CF) $10.7M $123.6M $71.2M $48.6M $45.9M
Foreign Exchange Rate Adjustment -$179.8K -$853.1K $1.7M -$1.8M $2.9M
Additions / Reductions $26.6M -$9.9M -$4.3M $61.4M -$17.8M
Ending Cash (CF) $37.1M $112.9M $68.6M $108.2M $31.1M
 
Levered Free Cash Flow -$3.1M -$11.5M -$45.4M -$11.5M -$2.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock